JPRN-UMIN000010521已完成4 期
A Double-blind Placebo Controlled Study of Mosapride citrate for Efficacy on Symptom Improvement of Patients with Functional Dyspepsia. - Efficacy Study of Mosapride for Functional Dyspepsia
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with conditions that are likely to cause upper abdominal symptoms such as malignant tumors, peptic ulcers and systemic diseases (neurological diseases including Parkinson's disease, metabolic diseases including diabetes, etc). 2. Patients with known causes of upper abdominal symptoms including excessive drinking, overeating, taking NSAIDs, and sever stress. 3. Patients with predominant GERD 4. Patients with predominant irritable bowel syndrome (IBS) 5. Patients with a history of surgery of the upper gastrointestinal tract including the stomach and esophagus. 6. Patients with severe hepatic dysfunction or renal dysfunction. 7. Patients with confirmed or suspected mental disorders. 8. Women who are pregnant or who wish to be pregnant during the study period, and lactating mother. 9. Other patients whom the investigator deems unsuitable for the study. 10. Patients who received H. pylori eradication therapy within 6 months from the visit or patients who are receiving the eradication therapy.
研究者
相似试验
已完成
不适用
Randomized Contorolled Trial of efficacy of mosapride plus omeprazole versus omeprazole alone in therapy of gastroesophageal reflux diseasegastroesophageal reflux diseaseJPRN-UMIN000000958Department of Gastroenterology, The University of Tokyo Hospital60
已完成
不适用
The open study for the effects of mosapride citrate on gastric ulcer healing after endoscopic submucosal disection.gastric ulcerJPRN-UMIN000003747Division of Gastroenterology, Kyoto Prefectural University of Medicine.20
进行中（未招募）
不适用
An open study comparing the effects of moxaverine on ocular blood flow in patients with age- related macular degeneration, primary open angle glaucoma and healthy control subjects - Moxaverine – Patients OPHT-011007glaucomaage-related macular degenerationMedDRA version: 9.1Level: LLTClassification code 10036719Term: Primary open angle glaucomaMedDRA version: 9.1Level: LLTClassification code 10064930Term: Age-related macular degenerationEUCTR2007-005607-18-ATrsapharm Arzneimittel GmbH & Co KG
进行中（未招募）
不适用
Safety and Efficacy of Cariprazine as an Adjunctive to AntidepressantTherapy in Major Depressive DisorderMajor Depressive DisorderEUCTR2011-005179-18-SKForest Research Institute, Inc810
进行中（未招募）
1 期
.MedDRA version: 16.1Level: LLTClassification code 10025454Term: Major depressive disorder, recurrent episodeSystem Organ Class: 100000004873MedDRA version: 16.1Level: LLTClassification code 10025463Term: Major depressive disorder, single episodeSystem Organ Class: 100000004873Major Depressive DisorderEUCTR2011-005179-18-SEForest Research Institute, Inc819